These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 17238201)

  • 1. Investigation of the effects of pharmaceutical processing upon solid-state NMR relaxation times and implications to solid-state formulation stability.
    Lubach JW; Xu D; Segmuller BE; Munson EJ
    J Pharm Sci; 2007 Apr; 96(4):777-87. PubMed ID: 17238201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of qualitative and quantitative analysis methods in pharmaceutical application with new selective signal excitation methods for 13 C solid-state nuclear magnetic resonance using 1 H T1rho relaxation time.
    Nasu M; Nemoto T; Mimura H; Sako K
    J Pharm Sci; 2013 Jan; 102(1):154-61. PubMed ID: 23147444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stable amorphous statin: solid-state NMR and dielectric studies on dynamic heterogeneity of simvastatin.
    Nunes TG; Viciosa MT; Correia NT; Danède F; Nunes RG; Diogo HP
    Mol Pharm; 2014 Mar; 11(3):727-37. PubMed ID: 24499472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of crystalline and amorphous forms of anhydrous neotame using 13C CPMAS NMR spectroscopy.
    Offerdahl TJ; Salsbury JS; Dong Z; Grant DJ; Schroeder SA; Prakash I; Gorman EM; Barich DH; Munson EJ
    J Pharm Sci; 2005 Dec; 94(12):2591-605. PubMed ID: 16258988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A solid-state NMR study of phase structure, molecular interactions, and mobility in blends of citric acid and paracetamol.
    Schantz S; Hoppu P; Juppo AM
    J Pharm Sci; 2009 May; 98(5):1862-70. PubMed ID: 18802950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of chiral defects in crystalline organic solids using solid-state NMR spectroscopy.
    Berendt RT; Munson EJ
    J Pharm Sci; 2011 May; 100(5):1879-91. PubMed ID: 21280054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of amorphous solid dispersions using 2D solid-state NMR and (1)H T(1) relaxation measurements.
    Pham TN; Watson SA; Edwards AJ; Chavda M; Clawson JS; Strohmeier M; Vogt FG
    Mol Pharm; 2010 Oct; 7(5):1667-91. PubMed ID: 20681586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
    Timmermann IL; Steckel H; Trunk M
    Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of molecular mobility in the glassy state between amorphous indomethacin and salicin based on spin-lattice relaxation times.
    Masuda K; Tabata S; Sakata Y; Hayase T; Yonemochi E; Terada K
    Pharm Res; 2005 May; 22(5):797-805. PubMed ID: 15906176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 19F solid-state NMR spectroscopic investigation of crystalline and amorphous forms of a selective muscarinic M3 receptor antagonist, in both bulk and pharmaceutical dosage form samples.
    Wenslow RM
    Drug Dev Ind Pharm; 2002 May; 28(5):555-61. PubMed ID: 12098844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of compaction-induced crystallinity reduction of a pharmaceutical solid using 19F solid-state NMR and powder X-ray diffraction.
    Liu J; Nagapudi K; Kiang YH; Martinez E; Jona J
    Drug Dev Ind Pharm; 2009 Aug; 35(8):969-75. PubMed ID: 19360510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of small amorphous amounts in hydrophilic and hydrophobic APIs on storage stability of dry powder inhalation products.
    Müller T; Krehl R; Schiewe J; Weiler C; Steckel H
    Eur J Pharm Biopharm; 2015 May; 92():130-8. PubMed ID: 25769680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystallization of amorphous indomethacin during dissolution: effect of processing and annealing.
    Greco K; Bogner R
    Mol Pharm; 2010 Oct; 7(5):1406-18. PubMed ID: 20459092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitation of a polymorphic mixture of an active pharmaceutical ingredient with solid state (13)C CPMAS NMR spectroscopy.
    Virtanen T; Maunu SL
    Int J Pharm; 2010 Jul; 394(1-2):18-25. PubMed ID: 20416365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the Particle Size and Polydispersity of Dicumarol Using Solid-State NMR Spectroscopy.
    Dempah KE; Lubach JW; Munson EJ
    Mol Pharm; 2017 Mar; 14(3):856-865. PubMed ID: 28166408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-state NMR in the analysis of drugs and naturally occurring materials.
    Paradowska K; Wawer I
    J Pharm Biomed Anal; 2014 May; 93():27-42. PubMed ID: 24173236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
    Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
    J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of DMA for the detection of amorphous content in pharmaceutical powdered materials.
    Royall PG; Huang CY; Tang SW; Duncan J; Van-de-Velde G; Brown MB
    Int J Pharm; 2005 Sep; 301(1-2):181-91. PubMed ID: 16026947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of ageing, grinding and preheating on the thermal behaviour of alpha-lactose monohydrate.
    Garnier S; Petit S; Mallet F; Petit MN; Lemarchand D; Coste S; Lefebvre J; Coquerel G
    Int J Pharm; 2008 Sep; 361(1-2):131-40. PubMed ID: 18617338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular dynamics of amorphous gentiobiose studied by solid-state NMR.
    Nunes TG; Diogo HP; Pinto SS; Moura Ramos JJ
    J Phys Chem B; 2010 Dec; 114(48):15976-84. PubMed ID: 21067127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.